VENDROME
Natural health product licensed in Canada
- Licence holder
- Neutrisci International
- NPN or DIN-HM
- 80026287
- Status
- Active licence
- Licence date
- 11 July 2011
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Niacine Source : Acide nicotinique | 15 mg | Not calculated |
| Ginseng (Panax ginseng) Source : Racine | 64 mg | Not calculated |
| Zinc Source : Citrate de zinc | 15 mg | 15,000 µg |
| Serenoa repens Source : Fruit lipidosterolic extract Potency : 82 % fatty acids | 320 mg | Not calculated |
| Rhodiola rosea Source : Root extract (standardised) Potency : 3 % rosavin | 50 mg | Not calculated |
| Cinnamomum aromaticum Source : Extrait de racine de l'écorce Extraction ratio : 30:1 Dry plant equivalent : 2,040 mg | 68 mg | Not calculated |
| Cnidium monnieri Source : Graine(s) | 30 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Amidon de maïs, silice, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Helps normal growth and development. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain healthy skin. Helps to maintain immune function. Helps in connective tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80026287
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.